SAN FRANCISCO--(BUSINESS WIRE)--Aug. 6, 2019-- JMP Group LLC (NYSE: JMP), an investment banking and alternative asset management firm, announced today that Reni Benjamin, Ph.D. has joined JMP Securities as a managing director and equity research analyst covering biotechnology. Based in the firm’s New York office, Dr. Benjamin will focus on the oncology sector.
“Ren will immediately be a key contributor to our healthcare franchise,” said Thomas Wright, director of equities at JMP Securities. “He is a well-recognized and well-respected analyst whose arrival renews JMP’s commitment to the oncology space—an area of tremendous importance to life sciences investors. Ren’s expertise and ability to distill complex information into actionable ideas will make him a valuable resource for our firm’s institutional and corporate clients alike.”
Dr. Benjamin joins JMP Securities from Raymond James, where he was a managing director and senior research analyst. Dr. Benjamin was previously a managing director at H.C. Wainwright & Co. and Rodman & Renshaw, after starting his career in biotechnology research at Needham & Company. Dr. Benjamin holds a Ph.D. in biochemistry and molecular genetics from the University of Alabama at Birmingham and a B.S. in biology from Allegheny College. He is a past member of the UAB School of Health Professions Dean'sAdvisory Board and currently serves on the advisory board of Phacilitate Cell & Gene Therapy.
About JMP Group
JMP Group LLC is a diversified capital markets firm that provides investment banking, equity research, and sales and trading services to corporate and institutional clients as well as alternative asset management products and services to institutional and high-net-worth investors. JMP Group conducts its investment banking and research, sales and trading activities through JMP Securities; its hedge fund, venture and private capital, and credit management activities through Harvest Capital Strategies and JMP Asset Management; and the management of Harvest Capital Credit Corporation (NASDAQ: HCAP), a business development company, through HCAP Advisors. For more information, visit www.jmpg.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190806005862/en/
Source: JMP Group LLC
Investor Relations Contact
JMP Group LLC
Media Relations Contacts
Dukas Linden Public Relations, Inc.